Please be advised that procedures connected with admission of Bioceltix S.A. shares to stock exchange trading are currently being finalized. ... More

Łukasz Bzdzion, President of the Management Board, participated in the XXX Economic Forum in Karpacz on behalf of Bioceltix. The second day of ... More

We made the next important step on the way to the registration of our drug candidates in the European Medicines Agency. The next phase of ... More

In connection with the issue of series G shares, on April 23, 2021, an increase in the share capital was registered. All formalities related to ... More

We would like to inform you that Dom Maklerski Banku Ochrony Środowiska S.A. has joined the group of consortium members accepting subscriptions ... More

On 02/03/2021 there was an investor chat with our participation. We invite you to watch the chat here: ... More

Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO ... More

Forbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the ... More

According to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large ... More

Gazeta Wrocławska wrote about us: “Bioceltix is ​​working on innovative biological medicines used in the treatment of common autoimmune and ... More